Hypertension is common among patients with diabetes, with the prevalence depending on
type and duration of diabetes, age, sex, race/ethnicity, BMI, history of glycemic control, and …

Type 2 diabetic kidney disease (DKD) is the most common cause of CKD and ESRD
worldwide, and carries with it enormous human and societal costs. The goal of this review is …

Diabetic kidney disease develops in approximately 40% of patients who are diabetic and is
the leading cause of CKD worldwide. Although ESRD may be the most recognizable …

Abstract The 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice
Guideline on the Evaluation and Care of Living Kidney Donors is intended to assist medical …

Background In a pooled analysis of short-term trials, short-term treatment with the sodium-
glucose co-transporter-2 (SGLT2) inhibitor empagliflozin reduced albuminuria in patients …

The renin-angiotensin-aldosterone system (RAAS) is a critical regulator of blood volume,
electrolyte balance, and systemic vascular resistance. While the baroreceptor reflex …

This article has been corrected. The original version (PDF) is appended to this article as a
Supplement. Description: The American College of Physicians (ACP) and the American …

Background: Type 2 diabetes mellitus is associated with an increased risk of hypertension,
and cardiovascular and renal disease, and it has been recommended that management of …

TGF-β has been implicated as a major pathogenic factor in diabetic nephropathy. This
randomized, double-blind, phase 2 study assessed whether modulating TGF-β1 activity with …

Diabetic nephropathy (DN) is the most common cause of end-stage kidney disease
worldwide, and is associated with increased morbidity and mortality in patients with both …